Assess Pyrogenic Risk In Pharmaceutical Process With The Monocyte Activation Test

Microbial risk in pharmaceutical process cannot be limited to viable microorganisms. Learn how the MAT can help you to assess the pyrogenic risk resulting from your production process.

The monocyte activation test (MAT) provides an in vitro alternative to conventional animal testing methods in accordance with regulatory guidelines.

Speakers: Mathilde Arnault, Research Scientist, Merck KGaA, Darmstadt, Germany